Reply by Authors.
Saved in:
| Title: | Reply by Authors. |
|---|---|
| Authors: | Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., McQuarrie K; Janssen Research & Development, Horsham, Pennsylvania., Bjartell A; Skåne University Hospital, Lund University, Malmö, Sweden., Chowdhury S; Guy's, King's, and St Thomas' Hospitals, and Sarah Cannon Research Institute, London, United Kingdom., Pereira de Santana Gomes AJ; Liga Norte Riograndense Contra O Câncer, Natal, Brazil., Chung BH; Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea., Özgüroğlu M; Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey., Juárez Soto Á; Hospital Universitario de Jerez de la Frontera, Cadiz, Spain., Merseburger AS; University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Uemura H; Kindai University Faculty of Medicine, Osaka, Japan., Ye D; Fudan University Shanghai Cancer Center, Shanghai, China., Given R; Urology of Virginia, Eastern Virginia Medical School, Norfolk, Virginia., Basch E; University of North Carolina, Chapel Hill, North Carolina., Miladinovic B; Janssen Research & Development, San Diego, California., Lopez-Gitlitz A; Janssen Research & Development, Los Angeles, California., Chi KN; BC Cancer, Vancouver, British Columbia, Canada. |
| Source: | The Journal of urology [J Urol] 2021 Oct; Vol. 206 (4), pp. 923. Date of Electronic Publication: 2021 Jul 23. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
